Hemlibra

Formula & Concentration

(emicizumab-kxwh)

Manufacturer

Genentech Inc

Indications

HEMLIBRA is a bispecific factor IXa- and factor X-directed antibody indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A (congenital factor VIII deficiency) with factor VIII inhibitors. (1)